Midday movers: Mobileye, Chipotle rise; Signet, BioNTech fall

BioNTech (BNTX) PT Lowered to $95 at TD Cowen

TD Cowen analyst Yaron Werber lowered the price target on BioNTech (NASDAQ: BNTX) to $95.00 (from $101.00) while maintaining a Market Perform rating.

The analyst comments "1.5B in Q4 Comirnaty sales missed consensus 1.8B due to write-downs from PFE & waning demand for COVID-19 boosters. FY24 revs... More

Tesla (TSLA) remains 'a relative winner in EVs long-term' - Morgan Stanley

Analysts at Morgan Stanley believe Tesla (NASDAQ: TSLA) remains a relative winner in EVs long-term, despite the recent challenges the company has faced.

"While we acknowledge the challenges to EV demand near-term (the Core Auto business only represents $68 of our $320 PT), we believe... More

Canaccord Genuity Reviews BioNTech (BNTX) Post Earnings

Canaccord Genuity analyst William Maughan reiterated a Buy rating and $171.00 price target on BioNTech (NASDAQ: BNTX).

The analyst comments "Shares of BNTX are down 8% (-1% NBI) today after BioNTech presented FY23/4Q23 results. FY23 revenue of 3.8B was roughly in line with previous guidance of 4B, while FY24 guidance was updated to 2.5-3.1B (prev. ~3B). Both of those updates are incrementally below previous expectations, which... More

BioNTech (BNTX) PT Lowered to $123 at BMO Capital

BMO Capital analyst Etzer Darout lowered the price target on BioNTech (NASDAQ: BNTX) to $123.00 (from $127.00) while maintaining a Outperform rating.

The analyst comments "BNTX reported FY23 revenues of 3.8B vs. our 4.3B and FY24 revenue guidance of 2.53.1B vs. our 3.1B. While BNTX's financial... More

Boeing (BA) PT Lowered to $210 at BofA Securities

BofA Securities analyst Ronald Epstein lowered the price target on Boeing (NYSE: BA) to $210.00 (from $225.00) while maintaining a Neutral rating.

The analyst comments "Despite being in a strong civil aviation market, we think Boeings shares are likely range bound for the time being... More

BofA Securities 'Incrementally positive on potential 2H recovery' for Intel (INTC)

BofA Securities analyst Vivek Arya reiterated a Neutral rating and $50.00 price target on Intel (NASDAQ: INTC).

The analyst comments "We hosted INTC CFO David Zinsner and IR Head John Pitzer for a well-attended investor dinner in Santa Clara on Tuesday. Management highlighted: 1) Enterprise AI... More

General Mills (GIS) PT Raised to $72 at BofA Securities, 'No rolling over'

BofA Securities analyst Bryan Spillane raised the price target on General Mills (NYSE: GIS) to $72.00 (from $68.00) while maintaining a Neutral rating.

The analyst comments "General Mills (GIS) reported 3Q24 earnings ahead of Street expectations on both sales and operating margin. Coming... More

Barclays Comments on Boeing (BA) MAX Deliveries

Barclays analyst David Strauss reiterated an Equalweight rating and $235.00 price target on Boeing (NYSE: BA)

The analyst comments "MAX deliveries consist of a mix of aircraft that were produced prior to the grounding being lifted in late 2020 (storage) along with aircraft that have been produced since then... More

General Mills (GIS) PT Raised to $70 at Deutsche Bank

Deutsche Bank analyst Steve Powers raised the price target on General Mills (NYSE: GIS) to $70.00 (from $68.00) while maintaining a Hold rating.

The analyst comments "GIS beat fiscal 3Q expectations ($1.17 EPS vs. Street $1.05) driven by (i) better-than-anticipated North America Retail (modest increase in... More

Boeing (BA) PT Lowered to $240 at Deutsche Bank

Deutsche Bank analyst Scott Deuschle lowered the price target on Boeing (NYSE: BA) to $240.00 (from $285.00) while maintaining a Buy rating.

The analyst comments "We are materially cutting our 2024-2027 EBIT, EPS, and FCF estimates. Changes to our model are summarized in the table... More

BioNTech (BNTX) PT Lowered to $91 at Goldman Sachs

Goldman Sachs analyst Chris Shibutani lowered the price target on BioNTech (NASDAQ: BNTX) to $91.00 (from $100.00) while maintaining a Neutral rating.

The analyst comments "BNTX reported 4Q23 earnings with Comirnaty (COVID-19 vaccine) sales coming in below expectations (1.48bn vs GS/Visible Alpha Consensus Data... More

JPMorgan Continues to See 2024 AS an 'execution year' for BioNTech (BNTX)

JPMorgan analyst Jessica Fye reiterated a Neutral rating and {REMOVEPT} price target on BioNTech (NASDAQ: BNTX)

The analyst comments "We continue to view 2024 as an execution year for BNTX with an aim to set the company up to achieve its longer-term goals (e.g., targeting... More

CFRA Stays Sidelined on Intel (INTC) Even Though 'we like potential growth prospects'

CFRA analyst Angelo Zino reiterated a Hold rating and $45.00 price target on Intel (NASDAQ: INTC).
The analyst comments "

INTC has been awarded $8.5B in grants from the CHIPs Act, in line with our expectation, which will be used to help support... More

BofA Review NVIDIA (NVDA) GTC, 'AI dominance continues in training + inference'

BofA Securities analyst Vivek Arya reiterated a Buy rating and $1,100.00 price target on NVIDIA (NASDAQ: NVDA).

The analyst comments "Maintain Buy, $1100 PO and top compute pick following financial analyst Q&A session at GTC 2024 (see our initial GTC takeaways report). Overall,... More

Morgan Stanley on General Mills (GIS) Following Earnings: 'We expect a positive share price reaction'

Morgan Stanley analyst Pamela Kaufman reiterated an Underweight rating and $58.00 price target on General Mills (NYSE: GIS).

The analyst comments "We expect a positive share price reaction to GISs Q3 results and reaffirmed FY24 guidance. GIS reported better than expected Q3 EPS of $1.17 vs. MSe/ consensus ($1.00/$1.05) driven by a 3% revenue beat vs. the Street and lower SG&A spend, that offset weaker than expected gross margins. Lower interest expense added $0.01 and a... More

Jefferies Reiterates Buy Rating on Boeing (BA), 'MAX Push to FCF and Margins'

Jefferies analyst Shelia Kahyaoglu reiterated a Buy rating and $300.00 price target on Boeing (NYSE: BA).

The analyst comments "We revisit 2024 FCF and delivery ests w/ BA guiding to a $4.0-4.5BB cash outflow ($2BB downside surprise) in Q1 and low $BBs... More

Boeing (BA) PT Lowered to $225 at RBC Capital, 'impact less than feared'

RBC Capital analyst Ken Herbert lowered the price target on Boeing (NYSE: BA) to $225.00 (from $260.00) while maintaining a Outperform rating.

The analyst comments "Boeing (BA) provided a significant update to its 2024 and 2025/2026 outlook at an investor conference today. For 2024, BA... More

UBS starts coverage of airline stocks, highlights 4 buy rated names

UBS started coverage of several airline stocks in separate notes Wednesday, highlighting four names it sees as buys.

Southwest Airlines (NYSE: LUV), American Airlines (NASDAQ: AAL), Alaska Air Group (NYSE: ALK), and Delta Air Lines (NYSE: DAL) are the airline stocks initiated with buy ratings, while United Airlines (NASDAQ: UAL) and Frontier Group Holdings, Inc.... More

Vertical Research Partners on Boeing (BA): 'myriad of problems'

Vertical Research Partners analyst Robert Stallard reiterated a Hold rating and $230.00 price target on Boeing (NYSE: BA).

The analyst comments "The first step towards fixing a problem is acknowledging that it exists. Boeings cut to its free cash flow guidance is an... More

Stifel Out Positive on Boeing (BA): 'We believe Boeing is on track to see build rates improve'

Stifel analyst Bert W. Subin reiterated a Buy rating and $270.00 price target on Boeing (NYSE: BA).

The analyst comments "This morning, Boeing's CFO made comments at a competitor conference that indicated -$4-4.5B of FCF in 1Q, some of which will not be made up for the year. This... More